Skip to main content
. Author manuscript; available in PMC: 2012 Oct 3.
Published in final edited form as: Neurosci Lett. 2011 Aug 17;503(2):83–86. doi: 10.1016/j.neulet.2011.08.005

Table 1.

Treatment Group Descriptors

Treatment Group Age (years) Gender rh5-HTTLPR distribution (n) Brain Weight (g) Body Weight (kg) Fluoxetine (ng/ml) Norfluoxetine (ng/ml)
Vehicle Alone (n = 12) 13.12 ± 1.64 50% Female l/l =5, s/l =6, s/s = 1 103.29 ± 9.72 9.54 ± 2.23 n/a n/a
Fluoxetine (n=12) 13.81 ± 2.51 50% Female l/l =6, s/l =4, s/s = 2 92.72 ± 11.60 8.19 ± 2.27 106.67 ± 44.19 313.25 ± 91.59